Source: Mehr News Agency, Tehran
About 75 percent of malignant and benign blood cancers as well as genetic and metabolic disease are being treated through cellular grafting in Iran.
"Seventy five percent of malignant and benign blood cancers and genetic and metabolic disease are curable through cellular grafting," according to Dr. Ardeshir Qavamzadeh.
Qavamzadeh made the announcement as the Iranian Society of Pediatric Hamatology and Oncology is set to host the 11th Iranian Congress of Medical Oncology and Hematology. Qavamzadeh is the secretary of the congress.
Specialists from the United States, Canada, France, Syria, Pakistan, and other countries will participate in the three-day congress. The Conference will be held on 25-27 April 2012 at Olympic Hotel in the city of Tehran.
... Payvand News - 04/22/12 ... --